| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $405.4M | -24.7% |
| Cost of Revenue | $1.6M | -17.3% |
| R&D Expense | $12.1M | +16.3% |
| SG&A Expense | $71.8M | -5.1% |
| Operating Income | -$102.7M | +18.3% |
| Pre-tax Income | -$106.4M | +14.8% |
| Income Tax | -$17.7M | +13.9% |
| Net Income | -$88.7M | +15.0% |
| EPS (Basic) | -$4.36 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.4M | +76.3% |
| Accounts Receivable | $2.6M | -54.2% |
| Current Assets | $401.1M | -1.6% |
| Total Assets | $1.11B | -3.2% |
| Current Liabilities | $60.6M | -19.7% |
| Long-term Debt | $66.1M | — |
| Total Liabilities | $198.4M | +18.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.9M | +83.5% |
| Capital Expenditures | $214K | -94.5% |
| Investing Cash Flow | $25.9M | +304.7% |
| Financing Cash Flow | $63.8M | -70.1% |
| Free Cash Flow | -$27.1M | +83.7% |
| +5.0% |
| EPS (Diluted) | -$4.36 | +5.0% |
| Stockholders' Equity |
| $651.0M |
| -13.2% |